Teachers Advisors LLC Purchases 16,648 Shares of Masimo Corporation (MASI)
Teachers Advisors LLC lifted its position in shares of Masimo Corporation (NASDAQ:MASI) by 5.4% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 326,915 shares of the medical equipment provider’s stock after purchasing an additional 16,648 shares during the quarter. Teachers Advisors LLC owned approximately 0.63% of Masimo Corporation worth $29,808,000 as of its most recent filing with the Securities and Exchange Commission.
Several other large investors have also recently made changes to their positions in MASI. Fortaleza Asset Management Inc. acquired a new stake in shares of Masimo Corporation during the 2nd quarter worth approximately $106,000. Neuburgh Advisers LLC grew its holdings in shares of Masimo Corporation by 6.4% during the 1st quarter. Neuburgh Advisers LLC now owns 1,328 shares of the medical equipment provider’s stock worth $124,000 after purchasing an additional 80 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in shares of Masimo Corporation by 32.2% during the 1st quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,782 shares of the medical equipment provider’s stock worth $166,000 after purchasing an additional 434 shares in the last quarter. Dubuque Bank & Trust Co. grew its holdings in shares of Masimo Corporation by 3.4% during the 2nd quarter. Dubuque Bank & Trust Co. now owns 1,869 shares of the medical equipment provider’s stock worth $170,000 after purchasing an additional 61 shares in the last quarter. Finally, Bancorpsouth Inc. acquired a new stake in shares of Masimo Corporation during the 1st quarter worth approximately $203,000. 83.21% of the stock is currently owned by institutional investors.
Shares of Masimo Corporation (NASDAQ:MASI) opened at 85.77 on Thursday. The firm has a market cap of $4.45 billion, a price-to-earnings ratio of 14.06 and a beta of 0.84. The company has a 50-day moving average price of $85.78 and a 200 day moving average price of $90.95. Masimo Corporation has a 52 week low of $53.78 and a 52 week high of $104.71.
Masimo Corporation (NASDAQ:MASI) last issued its quarterly earnings results on Wednesday, August 2nd. The medical equipment provider reported $0.83 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.71 by $0.12. The business had revenue of $192.90 million for the quarter, compared to the consensus estimate of $189.03 million. Masimo Corporation had a return on equity of 23.45% and a net margin of 45.90%. The firm’s quarterly revenue was up 11.8% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.57 earnings per share. Analysts expect that Masimo Corporation will post $2.80 EPS for the current fiscal year.
WARNING: “Teachers Advisors LLC Purchases 16,648 Shares of Masimo Corporation (MASI)” was reported by Watch List News and is the property of of Watch List News. If you are accessing this piece on another site, it was stolen and republished in violation of United States and international copyright law. The legal version of this piece can be accessed at https://www.watchlistnews.com/teachers-advisors-llc-purchases-16648-shares-of-masimo-corporation-masi/1577519.html.
MASI has been the topic of several recent research reports. Roth Capital lifted their price objective on Masimo Corporation from $96.00 to $105.00 and gave the stock a “buy” rating in a report on Wednesday, July 19th. Zacks Investment Research lowered Masimo Corporation from a “hold” rating to a “sell” rating in a report on Tuesday, July 4th. Stifel Nicolaus initiated coverage on Masimo Corporation in a report on Monday, July 10th. They set a “buy” rating and a $105.00 price objective on the stock. BidaskClub raised Masimo Corporation from a “hold” rating to a “buy” rating in a report on Wednesday, July 12th. Finally, BTIG Research raised Masimo Corporation from a “neutral” rating to a “buy” rating and set a $100.00 price objective on the stock in a report on Monday, August 14th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and four have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus target price of $95.00.
In related news, Director Sanford Fitch sold 11,000 shares of the stock in a transaction that occurred on Thursday, August 17th. The stock was sold at an average price of $87.25, for a total transaction of $959,750.00. Following the sale, the director now owns 72,249 shares of the company’s stock, valued at $6,303,725.25. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, COO Anand Sampath sold 40,000 shares of the stock in a transaction that occurred on Tuesday, July 11th. The stock was sold at an average price of $92.00, for a total value of $3,680,000.00. Following the sale, the chief operating officer now directly owns 20,000 shares in the company, valued at approximately $1,840,000. The disclosure for this sale can be found here. Insiders have sold 126,000 shares of company stock worth $11,732,930 in the last three months. 16.60% of the stock is currently owned by company insiders.
Masimo Corporation Profile
Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.
Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Corporation (NASDAQ:MASI).
Receive News & Ratings for Masimo Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.